Header Logo

Connection

Yuichi Sumii to Rituximab

Back to Details
This is a "connection" page, showing publications Yuichi Sumii has written about Rituximab.
Yuichi Sumii
Connection Strength
0.884
Rituximab
  1. Treatment outcomes of IgG4-producing marginal zone B-cell lymphoma: a retrospective case series. Int J Hematol. 2020 Dec; 112(6):780-786.
    View in: PubMed
    Score: 0.614
  2. Persistent hypogammaglobulinemia due to immunoglobulin class switch impairment by peri-transplant rituximab therapy. Int J Hematol. 2020 Sep; 112(3):422-426.
    View in: PubMed
    Score: 0.150
  3. Primary adrenal diffuse large B-cell lymphoma positive for CD5 and CD10. Rinsho Ketsueki. 2017; 58(2):161-164.
    View in: PubMed
    Score: 0.120
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.